Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
-2.02
↑ 91% above average
Average (6y)
-22.75
Historical baseline
Range
High:10.09
Low:-164.09
CAGR
-51.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -2.02 | +68.6% |
| 2023 | -6.44 | -9.7% |
| 2022 | -5.87 | -158.2% |
| 2021 | 10.09 | +77.5% |
| 2020 | 5.68 | +68.2% |
| 2019 | 3.38 | +102.1% |
| 2018 | -164.09 | - |